Has Linda Camp, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,639 in general payments to Linda Camp, MD across 57 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Linda Camp, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Linda Camp, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Linda Camp, MD

Plastic and Reconstructive Surgery · Columbiana, OHNPI 1225019516

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.1% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $492, 4.4 times the $112 reported in 2020. That places this record below the midpoint for plastic and reconstructive surgery clinicians in OH, where the typical reported total is $1,639.

$1,639in general payments, 2019–2025

Across 57 payments — averaging $28.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Revance Therapeutics, Inc.$383
Mentor Worldwide LLC$189
Myriad Genetic Laboratories, Inc.$173
Organogenesis Inc.$139
Musculoskeletal Transplant Foundation Inc.$120
Smith+Nephew$97
plus $537 from 17 others

What the payments were for

Travel & lodging$151%
Food & beverage$1,62399%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Revance Therapeutics, Inc.	8	$383
Mentor Worldwide LLC	4	$189
Myriad Genetic Laboratories, Inc.	2	$173
Organogenesis Inc.	2	$139
Musculoskeletal Transplant Foundation Inc.	10	$120
Smith+Nephew	5	$97
Vertex	2	$48
Abbott	2	$45
Merit Medical Systems Inc	2	$45
Molli Surgical (US) Inc	1	$45
Pacira Pharmaceuticals Incorporated	2	$44
Sientra, Inc.	2	$39
Bioventus LLC	2	$39
Johnson & Johnson	2	$34
Davol Inc.	1	$32
Integra Lifesciences Corporation	2	$30
Kowa Pharmaceuticals America, Inc.	2	$29
Baxter Healthcare	1	$26
Motiva USA, LLC	1	$23
Stryker	1	$16
AbbVie	1	$15
Medtronic	1	$14
Dilon Technologies, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,639 in reported general payments places this provider in the 50th percentile of 78 plastic and reconstructive surgery providers in Ohio.

See all plastic and reconstructive surgery providers in Ohio →

Medicare billing

Part B allowed, 2024

$42,199

Medicare patients

Services billed

327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cephalexin	17	$63
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	14	$63

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Columbiana

Paul VanekMentor$91K
Richard SimmanToledo$76K
Sunishka WimalawansaBeavercreek$68K
James GatherwrightCleveland$52K
Matthew GoldschmidtIndependence$47K
Katherine GrawePowell$44K
Abeer KalandarCleveland$34K
David MegeeCincinnati$25K
William AbouhassanColumbus$19K
Todd HicksDayton$15K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →